Lexaria Bioscience (LEXX) Change in Intangibles (2015 - 2026)

Lexaria Bioscience has disclosed Change in Intangibles across 12 years of filings, most recently posting $15094.0 for Q1 2026.

• Change in Intangibles for Q1 2026 came in at $15094.0, down 45.89% year-over-year; the trailing twelve-month figure through Feb 2026 was $54247.0 (down 39.47% YoY), and the FY2025 annual result was $75106.0, down 48.41% from the prior year.
• Change in Intangibles came in at $15094.0 for Q1 2026 at Lexaria Bioscience, up from $5099.0 in the prior quarter.
• In the past five years, Change in Intangibles ranged from a high of $68437.0 in Q3 2023 to a low of $5099.0 in Q4 2025.
• The 5-year median for Change in Intangibles is $26573.0 (2024), against an average of $28962.4.
• Across the five-year window, Change in Intangibles surged 1050.89% in 2022 and slumped 67.12% in 2024, its largest moves.
• Lexaria Bioscience's Change in Intangibles stood at $14342.0 in 2022, then jumped by 179.08% to $40026.0 in 2023, then plunged by 67.12% to $13159.0 in 2024, then sank by 61.25% to $5099.0 in 2025, then soared by 196.02% to $15094.0 in 2026.
• The last three Change in Intangibles figures came in at $15094.0 (Q1 2026), $5099.0 (Q4 2025), and $14610.0 (Q3 2025), per Business Quant data.